Table of Contents

company-logo

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Verve Therapeutics Dividend Announcement

• Verve Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Verve Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Verve Therapeutics Dividend History

Verve Therapeutics Dividend Yield

Verve Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Verve Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Verve Therapeutics Financial Ratios

P/E ratio-2.74
PEG ratio0.05
P/B ratio1.06
ROE-35.23%
Payout ratio0.00%
Current ratio13.05
Quick ratio13.11
Cash Ratio3.72

Verve Therapeutics Dividend FAQ

Does Verve Therapeutics stock pay dividends?
Verve Therapeutics does not currently pay dividends to its shareholders.
Has Verve Therapeutics ever paid a dividend?
No, Verve Therapeutics has no a history of paying dividends to its shareholders. Verve Therapeutics is not known for its dividend payments.
Why doesn't Verve Therapeutics pay dividends?
There are several potential reasons why Verve Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Verve Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Verve Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Verve Therapeutics a dividend aristocrat?
Verve Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Verve Therapeutics a dividend king?
Verve Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Verve Therapeutics a dividend stock?
No, Verve Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Verve Therapeutics stocks?
To buy Verve Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Verve Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.